Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Carcinoma, Non-Small-Cell Lung 11Neurofibromatosis 1 9Melanoma 6Neurofibroma, Plexiform 5Pancreatic Neoplasms 3Lung Neoplasms 3Colorectal Neoplasms 3Carcinoma, Hepatocellular 3Breast Neoplasms 3Triple Negative Breast Neoplasms 2Thyroid Neoplasms 2Thyroid Cancer, Papillary 2Sarcoma 2Neurofibrosarcoma 2Gallbladder Neoplasms 2Bile Duct Neoplasms 2Uveal Melanoma 1Thymoma 1Small Cell Lung Carcinoma 1Recurrence 1Peripheral Nervous System Diseases 1Non-small Cell Lung Cancer Metastatic 1Neuroma, Acoustic 1Neurofibromatosis 2 1Neuroblastoma 1Neoplasms, Nerve Tissue 1Neoplasm Metastasis 1Myelodysplastic-Myeloproliferative Diseases 1Myelodysplastic Syndromes 1Multiple Myeloma 1

Interventions

Bevacizumab 3Everolimus 2tozuleristide 1neratinib 1icotinib 1brigatinib 1Sirolimus 1Mn-PyC3A 1Losartan 1Lapatinib 1Fluoresceins 1Fluorescein 1Endostatins 1Axitinib 1Aspirin 1AZD 6244 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Neuroma, Acoustic × AZD 6244 × Clear all
NCT03095248 2025-04-22

SEL-TH-1601

Children's Hospital Medical Center, Cincinnati

Phase 2 Terminated
10 enrolled 9 charts
CNS

Ependymoma, Glioma, Meningioma, Neuroma, Acoustic, Neurofibromatosis 2

Data powered by HemOnc (CC BY 4.0) Colophon âš¡